Notification Letter with Change Request Form to Registered Shareholders

(incorporated in the Cayman Islands with limited liability) (于开曼群岛注册成立之有限公司) (Stock Code 股份代号: 1952) N OT IF IC ATI ON LET TE R 通 知 信 函 5 June 2024 Dear Shareholder(s) Everest Medicines Limited (the “Company”) - Notice of Publication of Annual General Meeting Circular and Proxy Form (the “Current Corporate Communication”) The English and Chinese versions of the Current Corporate Communication are available on the Company’s website at www.everestmedicines.com and are also available on the website of Hong Kong Exchanges and Clearing Limited (“HKEx”) at www.hkexnews.hk. If you have elected to receive Corporate Communications# in printed form the printed form (or forms) of the Current Corporate Communication is (or are) enclosed.If you would like (i) to receive future Corporate Communications from the Company in printed form instead of in electronic form on the Company’s website (or in electronic form on the Company’s website instead of in printed form) or (ii) to change the language in which you receive Corporate Communications in printed form please complete the Change Request Form on the reverse side of this letter and sign and return it by post or by hand to the Company c/o the Company’s share registrar in Hong Kong (the “Hong Kong Share Registrar”) Computershare Hong Kong Investor Services Limited at 17M Floor Hopewell Centre 183 Queen’s Road East Wan Chai Hong Kong. If you post your reply in Hong Kong you may use the mailing label in the Change Request Form and need not affix a stamp on the envelope when returning your Change Request Form. Otherwise please affix an appropriate stamp. You may also send an email with a scanned copy of the Change Request Form to everestmedicines.ecom@computershare.com.hk. The Change Request Form may also be downloaded from the Company’s website at www.everestmedicines.com or the website of HKEx at www.hkexnews.hk.If you have elected (or are deemed to have elected) to receive the Current Corporate Communication in electronic form on the Company’s website and for any reason have difficulty in obtaining access to Corporate Communications on the Company’s website the Company will upon request send the Current Corporate Communication to you in printed form free of charge.You may at any time by reasonable notice in writing to the Company (sent to the Hong Kong Share Registrar at the above address or by email to everestmedicines.ecom@computershare.com.hk) elect (i) to receive future Corporate Communications from the Company in printed form instead of in electronic form on the Company’s website (or in electronic form on the Company’s website instead of in printed form) or (ii) to change the language in which you receive Corporate Communications in printed form.Should you have any questions in relation to this letter please call the telephone hotline of the Hong Kong Share Registrar at (852) 2862 8688 during business hours from 9:00 a.m. to 6:00 p.m. Monday to Friday excluding Hong Kong public holidays.Yours faithfully By Order of the Board Everest Medicines Limited Wei Fu Chairman and Executive Director # Corporate communications are all documents issued by the Company to holders of its securities for their information or action and include (but are not limited to) full and summary annual and interim financial reports (and all reports and financial statements contained in them) notices of meetings listing documents circulars and proxy forms.各位股东： 云顶新耀有限公司（「公司」） –股东周年大会通函及代表委任表格（「本次公司通讯」）之发布通知 本次公司通讯之中、英文版本已上载于公司网站 (w ww . e v e r es t m e d i c i n e s . co m ) 及香港交易及结算所有限公司（「香港交易所」）网站 ( w w w .h k ex n ew s . hk )，欢迎查阅。如 阁下已选择收取公司通讯 #之印刷本，本次公司通讯随本函附上。 如 阁下欲 ( i )收取公司日后的公司通讯之印刷本，以取代于公司网站登载的电子本（或收取于公司网站登载的电子本，以取代印刷本）或( i i )更改所收取的公司通讯印刷本的语言版本，请 阁下填妥在本函背面的变更申请表，并在变更申请表上签名，然后把变更申请表寄回或亲手交回公司之香港证券登记处香港中央证券登记有限公司（「香港证券登记处」），地址为香港湾仔皇后大道东 1 83 号合和中心 1 7M 楼。倘若阁下在香港投寄，可使用变更申请表内的邮寄标签寄回，而毋须在信封上贴上邮票；否则，请贴上适当的邮票。阁下亦可把已填妥之变更申请表的扫描副本电邮至 ev e r e s t m e d i c i n e s . e co m @ c o mp ut e r s h a r e . c o m . hk 。变更申请表可于公司网站 ( ww w . ev e r e s t m e d i c i n e s . co m )或香港交易所网站 (w ww . hk e x n ew s . hk ) 内下载。 如阁下已选择（或被视为已同意）收取于公司网站登载的本次公司通讯电子本，惟因任何事故查阅公司通讯上出现困难，只要阁下提出要求，公司将尽快寄上所要求的本次公司通讯的印刷本，费用全免。 阁下可以随时透过香港证券登记处以书面方式寄送至上述地址或电邮至 e v e r e s t m e d i c in e s . e c o m @ c o m p ut e r s h a r e . c o m .h k 向公司作合理通知，选择 ( i )收取公司日后的公司通讯之印刷本，以取代于公司网站登载的电子本（或收取于公司网站登载的电子本，以取代印刷本）或 ( i i )更改所收取的公司通讯印刷本的语言版本。 阁下如有任何与本函内容有关的疑问，请致电香港证券登记处电话热线(852)28628688，办公时间为星期一至星期五（香港公众假期除外）上午9时正至下午6时正。 承董事会命云顶新耀有限公司主席兼执行董事傅唯谨启 2024年6月5日 #公司通讯乃本公司向其证券持有人发出以供参照或采取行动的任何文件，包括但不限于年度和中期财务报告及其摘要报告（及其中包含的所有报告及财务报表）、会议通告、上市文件、通函及委任代表表格。CCS9197 EMLHName(s) and address of Shareholder(s): 股东之姓名及地址: Change Request Form 变更申请表 To: Everest Medicines Limited (the “Company”) 致: 云顶新耀有限公司（「公司」） (Stock Code: 1952) （股份代号：1952） c/o Computershare Hong Kong Investor Services Limited 经香港中央证券登记有限公司 17M Floor Hopewell Centre 183 Queen’s Road East 香港湾仔皇后大道东 183 号 Wan Chai Hong Kong 合和中心 17M 楼 # I/We would like to receive corporate communications from the Company in the manner indicated below: # 本人／我们欲以下列方式收取本公司之公司通讯（「公司通讯」）： (Please mark “X” in ONLY ONE of the following boxes) (请从下列选择中，仅在其中一个空格内划上「X」号)to receive all future Corporate Communications in electronic form on the Company’s website at www.everestmedicines.com instead of receiving printed copies and to receive a printed notification letter for the publication of the relevant Corporate Communications on the website of the Company by post; OR 透过本公司网站 www.everestmedicines.com 收取所有日后的公司通讯电子本以代替收取印刷本，并以邮寄方式收取公司通讯文件已在网上刊发之通知信函印刷本；或 to receive the printed English version of all future Corporate Communications by post ONLY; OR仅以邮寄方式收取所有日后公司通讯文件之英文印刷本；或 to receive the printed Chinese version of all future Corporate Communications by post ONLY; OR仅以邮寄方式收取所有日后公司通讯文件之中文印刷本；或 to receive both the printed English and Chinese versions of all future Corporate Communications by post. 以邮寄方式同时收取所有日后公司通讯文件之英文及中文印刷本。 ______________________________________________________________________________________________________________________________ Signature(s) Contact Phone Number Date签署联络电话号码日期 Notes 附注: 1. Please c omplete all your details clearly. Please specify your name and address in ENGLISH BLOCK LETTERS on the top left hand corne r of this Change Request Form if you download this form from the web.请阁下清楚填妥所有资料。倘若阁下从网上下载本申请表格，请于本表格左上方用英文正楷注明阁下的姓名及地址。 2. If your shares are held in joint names the shareholder whose name stands first on the register of members of the Company in respect of the joint holding should sign on this Change Request Form in order to be valid.如属联名股东，则本变更申请表须由该名于本公司股东名册上就联名持有股份其姓名位列首位的股东签署，方为有效。 3. Any form with more than one box marked “X” with no box marked “X” with no signature or otherwise incorrectly completed will be void. 如在本表格作出超过一项选择、或未有作出选择、或未有签署、或在其他方面填写不正确，则本表格将会作废。 4. For the avoidance of doubt we do not accept any special instructions written on this Change Request Form. 为免存疑，任何在本变更申请表上的额外手写指示，本公司将不予处理。 # Corporate communications are all documents issued by the Company to holders o f its securities for their information or action and include (but are not limited to) full and summary annual and interim financial reports (and all reports and f inancial statements contained in them) notices of meetings listing documents circulars and proxy forms.公司通讯乃本公司向其证券持有人发出以供参照或采取行动的任何文件，包括但不限于年度和中期财务报告及其摘要报告（及其中包含的所有报告及财务报表）、会议通告、上市文件、通函及委任代表表格。 ?------------------------------------------------------ Mailing Label 邮寄标签 Please cut the mailing label and stick it on an envelope Get in touch with us 与我们联系 Computershare Hong Kong Investor Services Limited Send us an enquiry 垂询 to return this Change Request Form to us.Rate our service 评价 香港中央证券登记有限公司 No postage is necessary if posted in Hong Kong. Lodge a complaint 投诉 Freepost No. 简便回邮号码：37 Contact Us 联系我们 阁下寄回本变更申请表时，请将邮寄标签剪贴于信封上。 Hong Kong 香港 如在本港投寄， 阁下无需支付邮费或贴上邮票。 www.computershare.com/hk/contact? 0506202410